This report aims to provide a comprehensive presentation of the global market for Lung Cancer Liquid Biopsy, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Liquid Biopsy.

The Lung Cancer Liquid Biopsy market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lung Cancer Liquid Biopsy market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Cancer Liquid Biopsy manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

The global Lung Cancer Liquid Biopsy market size in 2022 is 300.00 million US dollars, and it is expected to be 1139.25 million US dollars by 2029, with a compound annual growth rate of 21.00% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Lung Cancer Liquid Biopsy market include Eurofins Scientific (Luxembourg), MDxHealth (Belgium), CareDx (U.S.), Immucor (U.S.), and Thermo Fisher Scientific Inc. (U.S.). The share of the top 3 players in the Lung Cancer Liquid Biopsy market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Lung Cancer Liquid Biopsy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. CTC (Circulating Tumor Cells) accounted for XX% of Lung Cancer Liquid Biopsy market in 2022. ctDNA (Circulating tumor DNA) share of XX%.
Small Cell Lung Cancer accounted for XX% of the Lung Cancer Liquid Biopsy market in 2022. Non-Small Cell Lung Cancer accounts for XX%.

Chapter Outline
Chapter 1: Introduces the product overview, and global Lung Cancer Liquid Biopsy market status and forecast by region.
Chapters 2-3: Segmented the global Lung Cancer Liquid Biopsy market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 4: Analysis of the competitive environment of Lung Cancer Liquid Biopsy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapters 5-9: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Lung Cancer Liquid Biopsy market country segmentation data.
Chapter 10: Analyzes the main companies in the Lung Cancer Liquid Biopsy industry, including their main businesses, products/services, revenue, gross margin, and the latest developments.
Chapter 11: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 12: The main points and conclusions of the report.
Chapter 13: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria

Player list
Eurofins Scientific (Luxembourg)
MDxHealth (Belgium)
CareDx (U.S.)
Immucor (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Menarini Silicon Biosystems (U.S.)
QIAGEN (Germany)
Guardant Health (U.S.)
Exact Sciences Corporation (U.S.)
Myriad Genetics, Inc. (U.S.)
LungLife AI, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Agilent Technologies Inc. (U.S.)
Natera, Inc. (U.S.)
CARDIFF ONCOLOGY, INC. (U.S.)
Exosome Diagnostics Inc. (U.S.)
Illumina, Inc. (U.S.)
Genomic Health Inc. (U.S.)
F. Hoffmann-La Roche Ltd (Switzerland)

Types list
CTC (Circulating Tumor Cells)
ctDNA (Circulating tumor DNA)
Exosomes and RNA

Application list
Small Cell Lung Cancer
Non-Small Cell Lung Cancer

Table of Content

1 Lung Cancer Liquid Biopsy Market Overview
1.1 Lung Cancer Liquid Biopsy Product Overview
1.1.1 Lung Cancer Liquid Biopsy Product Scope
1.1.2 Lung Cancer Liquid Biopsy Market Status and Outlook
1.2 Global Lung Cancer Liquid Biopsy Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Lung Cancer Liquid Biopsy Market Size by Region (2018-2029)
1.4 Global Lung Cancer Liquid Biopsy Historic Market Size by Region (2018-2023)
1.5 Global Lung Cancer Liquid Biopsy Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Lung Cancer Liquid Biopsy Market Size (2018-2029)
1.6.1 North America Lung Cancer Liquid Biopsy Market Size (2018-2029)
1.6.2 Europe Lung Cancer Liquid Biopsy Market Size (2018-2029)
1.6.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size (2018-2029)
1.6.4 Latin America Lung Cancer Liquid Biopsy Market Size (2018-2029)
1.6.5 Middle East & Africa Lung Cancer Liquid Biopsy Market Size (2018-2029)
2 Lung Cancer Liquid Biopsy Market Overview by Type
2.3 Global Lung Cancer Liquid Biopsy Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2018-2023)
2.5 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Lung Cancer Liquid Biopsy Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Lung Cancer Liquid Biopsy Market Size Breakdown by Type
2.6.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size Breakdown by Type
2.6.4 Latin America Lung Cancer Liquid Biopsy Market Size Breakdown by Type
2.6.5 Middle East and Africa Lung Cancer Liquid Biopsy Market Size Breakdown by Type
3 Lung Cancer Liquid Biopsy Market Overview by Application
3.3 Global Lung Cancer Liquid Biopsy Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2018-2023)
3.5 Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Lung Cancer Liquid Biopsy Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Lung Cancer Liquid Biopsy Market Size Breakdown by Application
3.6.3 Asia-Pacific Lung Cancer Liquid Biopsy Market Size Breakdown by Application
3.6.4 Latin America Lung Cancer Liquid Biopsy Market Size Breakdown by Application
3.6.5 Middle East and Africa Lung Cancer Liquid Biopsy Market Size Breakdown by Application
4 Lung Cancer Liquid Biopsy Competition Analysis by Players
4.1 Global Lung Cancer Liquid Biopsy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2022)
4.3 Date of Key Players Enter into Lung Cancer Liquid Biopsy Market
4.4 Global Top Players Lung Cancer Liquid Biopsy Headquarters and Area Served
4.5 Key Players Lung Cancer Liquid Biopsy Product Solution and Service
4.6 Competitive Status
4.6.1 Lung Cancer Liquid Biopsy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Lung Cancer Liquid Biopsy Market Segment by Country
5.1 North America Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Lung Cancer Liquid Biopsy Market Segment by Country
6.1 Europe Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Lung Cancer Liquid Biopsy Market Segment by Country
7.1 Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Lung Cancer Liquid Biopsy Market Segment by Country
8.1 Latin America Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Lung Cancer Liquid Biopsy Market Segment by Country
9.1 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1 Eurofins Scientific (Luxembourg)
10.1.1 Eurofins Scientific (Luxembourg) Information
10.1.2 Business Overview
10.1.3 Eurofins Scientific (Luxembourg) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.1.4 Lung Cancer Liquid Biopsy Products Offered
10.1.5 Eurofins Scientific (Luxembourg) Recent Development
10.2 MDxHealth (Belgium)
10.2.1 MDxHealth (Belgium) Information
10.2.2 Business Overview
10.2.3 MDxHealth (Belgium) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.2.4 Lung Cancer Liquid Biopsy Products Offered
10.2.5 MDxHealth (Belgium) Recent Development
10.3 CareDx (U.S.)
10.3.1 CareDx (U.S.) Information
10.3.2 Business Overview
10.3.3 CareDx (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.3.4 Lung Cancer Liquid Biopsy Products Offered
10.3.5 CareDx (U.S.) Recent Development
10.4 Immucor (U.S.)
10.4.1 Immucor (U.S.) Information
10.4.2 Business Overview
10.4.3 Immucor (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.4.4 Lung Cancer Liquid Biopsy Products Offered
10.4.5 Immucor (U.S.) Recent Development
10.5 Thermo Fisher Scientific Inc. (U.S.)
10.5.1 Thermo Fisher Scientific Inc. (U.S.) Information
10.5.2 Business Overview
10.5.3 Thermo Fisher Scientific Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.5.4 Lung Cancer Liquid Biopsy Products Offered
10.5.5 Thermo Fisher Scientific Inc. (U.S.) Recent Development
10.6 Menarini Silicon Biosystems (U.S.)
10.6.1 Menarini Silicon Biosystems (U.S.) Information
10.6.2 Business Overview
10.6.3 Menarini Silicon Biosystems (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.6.4 Lung Cancer Liquid Biopsy Products Offered
10.6.5 Menarini Silicon Biosystems (U.S.) Recent Development
10.7 QIAGEN (Germany)
10.7.1 QIAGEN (Germany) Information
10.7.2 Business Overview
10.7.3 QIAGEN (Germany) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.7.4 Lung Cancer Liquid Biopsy Products Offered
10.7.5 QIAGEN (Germany) Recent Development
10.8 Guardant Health (U.S.)
10.8.1 Guardant Health (U.S.) Information
10.8.2 Business Overview
10.8.3 Guardant Health (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.8.4 Lung Cancer Liquid Biopsy Products Offered
10.8.5 Guardant Health (U.S.) Recent Development
10.9 Exact Sciences Corporation (U.S.)
10.9.1 Exact Sciences Corporation (U.S.) Information
10.9.2 Business Overview
10.9.3 Exact Sciences Corporation (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.9.4 Lung Cancer Liquid Biopsy Products Offered
10.9.5 Exact Sciences Corporation (U.S.) Recent Development
10.10 Myriad Genetics, Inc. (U.S.)
10.10.1 Myriad Genetics, Inc. (U.S.) Information
10.10.2 Business Overview
10.10.3 Myriad Genetics, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.10.4 Lung Cancer Liquid Biopsy Products Offered
10.10.5 Myriad Genetics, Inc. (U.S.) Recent Development
10.11 LungLife AI, Inc. (U.S.)
10.11.1 LungLife AI, Inc. (U.S.) Information
10.11.2 Business Overview
10.11.3 LungLife AI, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.11.4 Lung Cancer Liquid Biopsy Products Offered
10.11.5 LungLife AI, Inc. (U.S.) Recent Development
10.12 Bio-Rad Laboratories, Inc. (U.S.)
10.12.1 Bio-Rad Laboratories, Inc. (U.S.) Information
10.12.2 Business Overview
10.12.3 Bio-Rad Laboratories, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.12.4 Lung Cancer Liquid Biopsy Products Offered
10.12.5 Bio-Rad Laboratories, Inc. (U.S.) Recent Development
10.13 Agilent Technologies Inc. (U.S.)
10.13.1 Agilent Technologies Inc. (U.S.) Information
10.13.2 Business Overview
10.13.3 Agilent Technologies Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.13.4 Lung Cancer Liquid Biopsy Products Offered
10.13.5 Agilent Technologies Inc. (U.S.) Recent Development
10.14 Natera, Inc. (U.S.)
10.14.1 Natera, Inc. (U.S.) Information
10.14.2 Business Overview
10.14.3 Natera, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.14.4 Lung Cancer Liquid Biopsy Products Offered
10.14.5 Natera, Inc. (U.S.) Recent Development
10.15 CARDIFF ONCOLOGY, INC. (U.S.)
10.15.1 CARDIFF ONCOLOGY, INC. (U.S.) Information
10.15.2 Business Overview
10.15.3 CARDIFF ONCOLOGY, INC. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.15.4 Lung Cancer Liquid Biopsy Products Offered
10.15.5 CARDIFF ONCOLOGY, INC. (U.S.) Recent Development
10.16 Exosome Diagnostics Inc. (U.S.)
10.16.1 Exosome Diagnostics Inc. (U.S.) Information
10.16.2 Business Overview
10.16.3 Exosome Diagnostics Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.16.4 Lung Cancer Liquid Biopsy Products Offered
10.16.5 Exosome Diagnostics Inc. (U.S.) Recent Development
10.17 Illumina, Inc. (U.S.)
10.17.1 Illumina, Inc. (U.S.) Information
10.17.2 Business Overview
10.17.3 Illumina, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.17.4 Lung Cancer Liquid Biopsy Products Offered
10.17.5 Illumina, Inc. (U.S.) Recent Development
10.18 Genomic Health Inc. (U.S.)
10.18.1 Genomic Health Inc. (U.S.) Information
10.18.2 Business Overview
10.18.3 Genomic Health Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.18.4 Lung Cancer Liquid Biopsy Products Offered
10.18.5 Genomic Health Inc. (U.S.) Recent Development
10.19 F. Hoffmann-La Roche Ltd (Switzerland)
10.19.1 F. Hoffmann-La Roche Ltd (Switzerland) Information
10.19.2 Business Overview
10.19.3 F. Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Liquid Biopsy Revenue, Gross Margin
10.19.4 Lung Cancer Liquid Biopsy Products Offered
10.19.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
11 Lung Cancer Liquid Biopsy Market Dynamics
11.1 Lung Cancer Liquid Biopsy Industry Trends
11.2 Lung Cancer Liquid Biopsy Growth Drivers
11.3 Lung Cancer Liquid Biopsy Market Challenges
11.4 Lung Cancer Liquid Biopsy Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer

List of Tables and Figures

Table Global Lung Cancer Liquid Biopsy Market Size Overview by Region 2018 VS 2022VS 2029
Table Global Lung Cancer Liquid Biopsy Market Size by Region (2018-2029)
Table Global Lung Cancer Liquid Biopsy Market Size by Region (2018-2023)
Table Global Lung Cancer Liquid Biopsy Market Size by Region (2023-2029)
Figure North America Lung Cancer Liquid Biopsy Market Size (US$ Million) Growth Rate (2018-2029)
Figure Europe Lung Cancer Liquid Biopsy Market Size (US$ Million) Growth Rate (2018-2029)
Figure Asia-Pacific Lung Cancer Liquid Biopsy Market Size (US$ Million) Growth Rate (2018-2029)
Figure Latin America Lung Cancer Liquid Biopsy Market Size (US$ Million) Growth Rate (2018-2029)
Figure Middle East & Africa Lung Cancer Liquid Biopsy Market Size (US$ Million) Growth Rate (2018-2029)
Table Global Lung Cancer Liquid Biopsy Market Size by Type: 2018 VS 2022 VS 2029
Table Global Lung Cancer Liquid Biopsy Historic Market Size by Type (2018-2023)
Table Global Lung Cancer Liquid Biopsy Forecasted Market Size by Type (2023-2029)
Table North America Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Type
Table Europe Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Type
Table Asia-Pacific Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Type
Table Latin America Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Type
Table Middle East and Africa Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Type
Table Global Lung Cancer Liquid Biopsy Market Size by Application: 2018 VS 2022 VS 2029
Table Global Lung Cancer Liquid Biopsy Historic Market Size by Application (2018-2023)
Table Global Lung Cancer Liquid Biopsy Forecasted Market Size by Application (2023-2029)
Table North America Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Application
Table Europe Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Application
Table Asia-Pacific Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Application
Table Latin America Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Application
Table Middle East and Africa Lung Cancer Liquid Biopsy Market Size Breakdown in Value, by Application
Table Global Lung Cancer Liquid Biopsy Market Size by Players (2018-2023)
Table Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biopsy as of 2022)
Table Date of Key Players Enter into Lung Cancer Liquid Biopsy Market
Table Global Top Players Lung Cancer Liquid Biopsy Headquarters and Area Served
Table Key Players Lung Cancer Liquid Biopsy Product Solution and Service
Table Lung Cancer Liquid Biopsy Market Concentration Rate
Table Mergers & Acquisitions, Expansion Plans
Table North America Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
Figure United States Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Canada Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Table Europe Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
Figure Germany Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure France Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure U.K.Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Italy Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Russia Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Nordic Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Rest of Europe Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Table Asia-Pacific Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
Figure China Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Japan Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure South Korea Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Southeast Asia Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure India Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Australia Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Rest of Asia-Pacific Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Table Latin America Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
Figure Mexico Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Brazil Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Rest of Latin America Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Table Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Country (2018-2029)
Figure Turkey Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Saudi Arabia Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure UAE Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Figure Rest of Middle East & Africa Lung Cancer Liquid Biopsy Market Size and Growth Rate 2018-2029
Table Eurofins Scientific (Luxembourg) Basic Information
Table Eurofins Scientific (Luxembourg) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Eurofins Scientific (Luxembourg) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Eurofins Scientific (Luxembourg) Recent Development
Table MDxHealth (Belgium) Basic Information
Table MDxHealth (Belgium) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure MDxHealth (Belgium) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table MDxHealth (Belgium) Recent Development
Table CareDx (U.S.) Basic Information
Table CareDx (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure CareDx (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table CareDx (U.S.) Recent Development
Table Immucor (U.S.) Basic Information
Table Immucor (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Immucor (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Immucor (U.S.) Recent Development
Table Thermo Fisher Scientific Inc. (U.S.) Basic Information
Table Thermo Fisher Scientific Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Thermo Fisher Scientific Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Thermo Fisher Scientific Inc. (U.S.) Recent Development
Table Menarini Silicon Biosystems (U.S.) Basic Information
Table Menarini Silicon Biosystems (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Menarini Silicon Biosystems (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Menarini Silicon Biosystems (U.S.) Recent Development
Table QIAGEN (Germany) Basic Information
Table QIAGEN (Germany) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure QIAGEN (Germany) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table QIAGEN (Germany) Recent Development
Table Guardant Health (U.S.) Basic Information
Table Guardant Health (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Guardant Health (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Guardant Health (U.S.) Recent Development
Table Exact Sciences Corporation (U.S.) Basic Information
Table Exact Sciences Corporation (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Exact Sciences Corporation (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Exact Sciences Corporation (U.S.) Recent Development
Table Myriad Genetics, Inc. (U.S.) Basic Information
Table Myriad Genetics, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Myriad Genetics, Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Myriad Genetics, Inc. (U.S.) Recent Development
Table LungLife AI, Inc. (U.S.) Basic Information
Table LungLife AI, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure LungLife AI, Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table LungLife AI, Inc. (U.S.) Recent Development
Table Bio-Rad Laboratories, Inc. (U.S.) Basic Information
Table Bio-Rad Laboratories, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Bio-Rad Laboratories, Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Bio-Rad Laboratories, Inc. (U.S.) Recent Development
Table Agilent Technologies Inc. (U.S.) Basic Information
Table Agilent Technologies Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Agilent Technologies Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Agilent Technologies Inc. (U.S.) Recent Development
Table Natera, Inc. (U.S.) Basic Information
Table Natera, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Natera, Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Natera, Inc. (U.S.) Recent Development
Table CARDIFF ONCOLOGY, INC. (U.S.) Basic Information
Table CARDIFF ONCOLOGY, INC. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure CARDIFF ONCOLOGY, INC. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table CARDIFF ONCOLOGY, INC. (U.S.) Recent Development
Table Exosome Diagnostics Inc. (U.S.) Basic Information
Table Exosome Diagnostics Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Exosome Diagnostics Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Exosome Diagnostics Inc. (U.S.) Recent Development
Table Illumina, Inc. (U.S.) Basic Information
Table Illumina, Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Illumina, Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Illumina, Inc. (U.S.) Recent Development
Table Genomic Health Inc. (U.S.) Basic Information
Table Genomic Health Inc. (U.S.) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure Genomic Health Inc. (U.S.) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table Genomic Health Inc. (U.S.) Recent Development
Table F. Hoffmann-La Roche Ltd (Switzerland) Basic Information
Table F. Hoffmann-La Roche Ltd (Switzerland) Lung Cancer Liquid Biopsy Revenue, Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Revenue Market Share 2018-2023
Table Lung Cancer Liquid Biopsy Products Offered
Table F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report